How does bile acid-induced IRF3 phosphorylation mediate cholestatic liver and kidney injury?-More needs to be known

被引：0
|
作者：
Jiang, Lingzhen [1 ]
Yang, Zaixing [2 ,3 ]
机构：
[1] Taizhou First Peoples Hosp, Dept Comprehens Med Serv Ctr, Taizhou, Zhejiang, Peoples R China
[2] Taizhou First Peoples Hosp, Dept Lab Med, Taizhou, Zhejiang, Peoples R China
[3] Taizhou First Peoples Hosp, 218 Hengjie Rd, Taizhou, Zhejiang, Peoples R China
来源：
HEPATOLOGY | 2024年 / 80卷 / 01期
关键词：
D O I：
10.1097/HEP.0000000000000813
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：E1 / E1
页数：1
相关论文
共 11 条
  • [1] Reply to: How does bile acid-induced IRF3 phosphorylation mediate cholestatic liver and kidney injury? more need to be known
    Zhuang, Yuan
    Szabo, Gyongyi
    HEPATOLOGY, 2024, 80 (01) : E2 - E3
  • [2] Bile acid-induced IRF3 phosphorylation mediates cell death, inflammatory responses, and fibrosis in cholestasis-induced liver and kidney injury via regulation of ZBP1
    Zhuang, Yuan
    Ortega-Ribera, Marti
    Thevkar Nagesh, Prashanth
    Joshi, Radhika
    Huang, Huihui
    Wang, Yanbo
    Zivny, Adam
    Mehta, Jeeval
    Parikh, Samir M.
    Szabo, Gyongyi
    HEPATOLOGY, 2024, 79 (04) : 752 - 767
  • [3] Bid antisense attenuates bile acid-induced apoptosis and cholestatic liver injury
    Higuchi, H
    Miyoshi, H
    Bronk, SF
    Zhang, H
    Dean, N
    Gores, GJ
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2001, 299 (03): : 866 - 873
  • [4] Resistance of rat hepatocytes against bile acid-induced apoptosis in cholestatic liver injury is due to nuclear factor-kappa B activation
    Schoemaker, MH
    Gommans, WA
    Conde de la Rosa, L
    Homan, M
    Klok, P
    Trautwein, C
    van Goor, H
    Poelstra, K
    Haisma, HJ
    Jansen, PLM
    Moshage, H
    JOURNAL OF HEPATOLOGY, 2003, 39 (02) : 153 - 161
  • [5] MicroRNA-210 Promotes Bile Acid-Induced Cholestatic Liver Injury by Targeting Mixed-Lineage Leukemia-4 Methyltransferase in Mice
    Kim, Young-Chae
    Jung, Hyunkyung
    Seok, Sunmi
    Zhang, Yang
    Ma, Jian
    Li, Tiangang
    Kemper, Byron
    Kemper, Jongsook Kim
    HEPATOLOGY, 2020, 71 (06) : 2118 - 2134
  • [6] Prevention of bile acid-induced apoptosis with omega-3 long-chain polyunsaturated fatty acids in a cholestatic liver disease model.
    Howze, Timothy J.
    McGlaughlin, Brent
    Guan, Peihong
    Helms, Richard A.
    Tillman, Emma M.
    PHARMACOTHERAPY, 2014, 34 (10): : E282 - E283
  • [7] TGF-β-SMAD3 signaling mediates hepatic bile acid and phospholipid metabolism following lithocholic acid-induced liver injury
    Matsubara, Tsutomu
    Tanaka, Naoki
    Sato, Misako
    Kang, Dong Wook
    Krausz, Kristopher W.
    Flanders, Kathleen C.
    Ikeda, Kazuo
    Luecke, Hans
    Wakefield, Lalage M.
    Gonzalez, Frank J.
    JOURNAL OF LIPID RESEARCH, 2012, 53 (12) : 2698 - 2707
  • [8] BILE ACID-INDUCED UPREGULATION OF MICRORNA 155 PROMOTES CHOLESTATIC LIVER INJURY VIA TARGETING THE INSIG2/SREBP1 PATHWAY IN MDR2-/- MICE.
    Zhang, Yuan
    Wang, Rui
    Wang, Yanyan
    Tai, Yunling
    Ge, Pu
    Wu, Jilin
    Yang, Wilson
    Zhao, Derrick
    Wang, Xuan
    Gurley, Emily
    Hylemon, Phillip
    Wang, Weilin
    Zhou, Huiping
    GASTROENTEROLOGY, 2020, 158 (06) : S1262 - S1262
  • [9] Investigating bile acid-mediated cholestatic drug-induced liver injury using a mechanistic model of multidrug resistance protein 3 (MDR3) inhibition
    Beaudoin, James J.
    Yang, Kyunghee
    Adiwidjaja, Jeffry
    Taneja, Guncha
    Watkins, Paul B.
    Siler, Scott Q.
    Howell, Brett A.
    Woodhead, Jeffrey L.
    FRONTIERS IN PHARMACOLOGY, 2023, 13
  • [10] Risk Factors for Development of Cholestatic Drug-Induced Liver Injury: Inhibition of Hepatic Basolateral Bile Acid Transporters Multidrug Resistance-Associated Proteins 3 and 4
    Koeck, Kathleen
    Ferslew, Brian C.
    Netterberg, Ida
    Yang, Kyunghee
    Urban, Thomas J.
    Swaan, Peter W.
    Stewart, Paul W.
    Brouwer, Kim L. R.
    DRUG METABOLISM AND DISPOSITION, 2014, 42 (04) : 665 - 674
12